Cannabis Sativa (CBDS) 10-K 6 May 16 2015 FY Annual report Financial data

Document and Entity Information

Document and Entity Information - USD ($)	12 Months Ended
	Dec. 31, 2015	Apr. 14, 2016	Jun. 30, 2015
Document and Entity Information:
Entity Registrant Name	Cannabis Sativa, Inc.
Document Type	10-K
Document Period End Date	Dec. 31, 2015
Amendment Flag	false
Entity Central Index Key	1,360,442
Current Fiscal Year End Date	--12-31
Entity Common Stock, Shares Outstanding		16,154,738
Entity Filer Category	Smaller Reporting Company
Entity Current Reporting Status	Yes
Entity Voluntary Filers	No
Entity Well-known Seasoned Issuer	No
Document Fiscal Year Focus	2,015
Document Fiscal Period Focus	FY
Entity Public Float			$ 14,731,867
Entity Incorporation, Date of Incorporation	Nov. 5, 2004
Trading Symbol	cbds

CONSOLIDATED BALANCE SHEETS

CONSOLIDATED BALANCE SHEETS - USD ($)	Dec. 31, 2015	Dec. 31, 2014
Current Assets
Cash and Cash Equivalents	$ 10,356	$ 25,994
Digital Currency	5,203
Accounts Receivable, Net	4,190
Employee Advance	44	13
Inventories	24,937	17,837
Available-for-Sale Securities		4,876
Investment in Joint Venture	35,000
Prepaids		625,000
Total Current Assets	79,730	673,720
Property and Equipment, Net	4,504	7,037
Intangible Assets, Net	2,904,121	2,999,292
Investment	9,760
Due from Related Parties	248,182
Deposits	4,236	1,031
Total Assets	3,250,533	3,681,080
Current Liabilities:
Accounts Payable and Accrued Expenses	344,395	482,942
Due to Related Parties - Short Term	27,427	2,472,086
Accrued Interest		5,667
Total Current Liabilities	371,822	2,960,695
Due to Related Parties - Long Term		1,000,000
Total Liabilities	371,822	3,960,695
Stockholders' Equity (Deficit):
Preferred stock $0.001 par value; 5,000,000 shares authorized; 428,585 and -0- issued and outstanding, respectively	429
Common stock $0.001 par value; 45,000,000 shares authorized; 17,374,738 and 15,114,738 shares issued and outstanding, respectively	17,375	15,115
Stock Subscriptions Payable	14,303
Additional Paid-In Capital	56,938,810	46,614,604
Accumulated Other Comprehensive Income		4,876
Accumulated Deficit	(54,093,099)	(46,915,104)
Total Cannabis Sativa, Inc. Stockholders' Equity (Deficit)	2,877,817	(280,509)
Non-Controlling Interest	894	894
Total Stockholders' Equity (Deficit)	2,878,711	(279,615)
Total Liabilities and Stockholders' Equity (Deficit)	$ 3,250,533	$ 3,681,080

CONDENSED CONSOLIDATED BALANCE

CONDENSED CONSOLIDATED BALANCE SHEETS (PARENTHETICAL) - $ / shares	Dec. 31, 2015	Dec. 31, 2014
Statement of Financial Position
Common Stock, par or stated value	$ 0.001	$ 0.001
Common Stock, shares authorized	45,000,000	45,000,000
Common Stock, shares issued	17,374,738	15,114,738
Common Stock, shares outstanding	17,374,738	15,114,738
Preferred Stock, par or stated value	$ 0.001	$ 0.001
Preferred Stock, shares authorized	5,000,000	5,000,000
Preferred Stock, shares issued	428,585	0
Preferred Stock, shares outstanding	428,585	0

CONSOLIDATED STATEMENTS OF OPER

CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
Income Statement
Revenues	$ 11,610	$ 7,151
Cost of Revenues	5,787	2,425
Gross Profit (Loss)	5,823	4,726
Impairment Expense		13,070,346
Research and Development Expenses		3,712
General and Administrative Expenses	7,303,371	1,323,415
Loss from Operations	(7,297,548)	(14,392,747)
Other Expenses
Gain on Sale of Asset		49,512
Interest Expense	(26,871)	(26,497)
Loss from Continuing Operations Before Discontinued Operations	(7,324,419)	(14,369,732)
Loss from Discontinued Operations	(108,440)
Loss Before Income Taxes	$ (7,432,859)	$ (14,369,732)
Income Taxes
Loss from Continuing Operations	$ (7,432,859)	$ (14,369,732)
Net Loss	$ (7,432,859)	$ (14,369,732)
Loss Attributable to Non-Controlling Interest
Net Loss Attributable To Cannabis Sativa, Inc.	$ (7,432,859)	$ (14,369,732)
Net Loss per Common Share:
Basic & Diluted Continuing Operations	$ (0.46)	$ (1.14)
Basic & Diluted Discontinued Operations	$ (0.01)	$ 0
Weighted Average Common Shares Outstanding:
Basic & Diluted	16,177,539	12,573,865

CONSOLIDATED STATEMENTS OF CASH

CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
CASH FLOWS FROM OPERATING ACTIVITIES:
Net Loss	$ (7,432,859)	$ (14,369,732)
Adjustments to Reconcile Net Loss to Net Cash Used in Operating Activities:
Depreciation and Amortization	103,614	78,881
Stock Issued for Services	6,540,425	375,000
Contributed Capital		54,582
Amortization of Note Discount		5,559
Imputed Interest on Loans	25,978
Impairment of Goodwill		13,070,346
Gain on Sale of Patent		(49,512)
Realized Gain on Available for Sale Securities		(7,723)
Bad Debt Expense	0	3,697
Changes in assets and liabilities:
Digital Currency	(473)
Accounts Receivable	(4,190)	(3,697)
Inventories	(7,100)	(12,084)
Employeee Advances	(31)	(13)
Prepaids	625,000
Deposits	(3,205)	(150)
Accounts Payable and Accrued Expenses	(138,547)	450,332
Accounts Payable and Accrued Expenses - Kush	6,084
Intercompany Accounts, Net Payable		(5,315)
Accrued Interest		1,348
Net Cash Used in Operating Activities:	(285,304)	(408,481)
Net Cash Provided by Discontinued Operating Activities:	6,840
Cash Flows from Investing Activities:
Purchase of Fixed Assets and Intangibles	(8,410)	(21,625)
Sale of Fixed Assets and Intangibles		50,000
Proceeds from Sale of Available for Sale Securities		147,723
Cash Acquired in Merger		27,707
Investment in Joint Venture (in AP)	(35,000)
Spin-Off	108,440
Net Cash Provided (Used) in Investing Activities:	$ 65,030	$ 203,805
Net Cash Provided by Discontinued Investing Activities:
Cash Flows from Financing Activities:
Payments to Related Parties	$ (164,406)	$ (109,143)
Proceeds from Related Parties	362,202	324,950
Net Cash Provided by Financing Activities:	$ 197,796	$ 215,807
Net Cash Provided by Discontinued Financing Activities:
NET INCREASE IN CASH AND CASH EQUIVALENTS	$ (15,638)	$ 11,131
Cash and Cash Equivalents - Beginning of Year	25,994	14,863
Cash and Cash Equivalents - End of Year	$ 10,356	$ 25,994
Supplemental Disclosure of Cash Flow Activities:
Interest
Income taxes
Supplemental Disclosures of Non Cash Activities:
Conversion of debt to equity		$ 78,112
Acquisition of assets in merger		3,198,258
Unrealized Gain on Available for Sale Securities	$ 0	$ 4,876
Shares issued for accrued liabilities	362,250
Shares issued for prepaid items	3,246,925
Preferred shares issued for related party payables	$ 3,747,668

STATEMENTS OF CHANGES IN STOCKH

STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (DEFICIT) - USD ($)	Preferred Stock $ .001 Par	Common Stock $ .001 Par	Stock Subscriptions Payable	Additional Paid-In Capital		Accumulated Other Comprehensive Income	Accumulated Deficit	Non-Controlling Interest	Total
Stockholders' Equity, beginning of period, Value at Dec. 31, 2013		$ 7,825		$ 33,022			$ (32,545,372)		$ (32,504,525)
Stockholders' Equity, beginning of period, Shares at Dec. 31, 2013		7,825,000
Conversion of Debt to Equity, Value		$ 3,889		32,327,664					32,331,553
Conversion of Debt to Equity, Shares		3,889,071
Shares Issued for Kush Acquistion, Value		$ 3,301		13,199,435					13,202,736
Shares Issued for Kush Acquistion, Shares		3,300,667
Shares Issued for Services, Value		$ 100		999,900					1,000,000
Shares Issued for Services, Shares		100,000
Contributed Capital				54,583					54,583
Non-Controlling Interest in KPAL, Inc.								$ 894	894
Change in Fair Market Value of Available for Sale Securities						$ 4,876			4,876
Net Loss							(14,369,732)		(14,369,732)
Stockholders' Equity, end of period, Value at Dec. 31, 2014		$ 15,115		46,614,604		4,876	(46,915,104)	894	(279,615)
Stockholders' Equity, end of period, Shares at Dec. 31, 2014		15,114,738
Conversion of Debt to Equity, Shares	1,928,585
Shares Issued for Services, Value		$ 1,010	$ 14,000	6,525,415					6,540,425
Shares Issued for Services, Shares		1,010,000
Preferred Stock Issued due to Decrease in Market Value			303	(303)
Spin-Off, Value	$ (1,500)	$ 1,250		10,010		$ (4,876)	254,864		259,748
Spin-Off, Shares	(1,500,000)	1,250,000
Imputed Interest on Loans				33,300					33,300
Contributed Capital				5,312	[1]				5,312
Investment in Hemp Coins				4,731					4,731
Net Loss							(7,432,859)		(7,432,859)
Preferred Stock Issued for Related Party Debt, Value	$ 1,929			3,745,741					3,747,670
Stockholders' Equity, end of period, Value at Dec. 31, 2015	$ 429	$ 17,375	$ 14,303	$ 56,938,810			$ (54,093,099)	$ 894	$ 2,878,711
Stockholders' Equity, end of period, Shares at Dec. 31, 2015	428,585	17,374,738
[1]	Contibuted by Shareholder

1. Summary of Significant Accou

1. Summary of Significant Accounting Policies and Use of Estimates	12 Months Ended
	Dec. 31, 2015
Notes
1. Summary of Significant Accounting Policies and Use of Estimates:	1. Summary of Significant Accounting Policies and Use of Estimates: Nature of Corporation: We were incorporated under the laws of Nevada in November 2004 as Ultra Sun Corp. On November 13, 2013, we changed our name to Cannabis Sativa, Inc. Our wholly-owned subsidiary Kush was acquired by us in June 2014 in exchange for shares of our common stock. Our wholly-owned subsidiary Wild Earth Naturals, Inc. ("Wild Earth") was acquired by us in July 2013 in exchange for shares of our common stock. The acquisition of Kush resulted in a change of control of the Company and at or after the closing of the acquisition of Kush, the persons designated by Kush became the officers and directors of the Company. From our inception through September 30, 2013 we were engaged in the tanning salon business and operated a tanning salon in Saratoga Springs, Utah under the name "Sahara Sun Tanning." As a result of our acquisition of Wild Earth in July 2013, we became engaged in the herbal skin care products business. On September 30, 2013 we sold the assets of the tanning salon business to a third party. As a result of our acquisition of Kush in June 2014, along with our Wild Earth operations we are now engaged in the developing and promoting of natural cannabis products. On November 2, 2015, Kush was spun out of the Company. Cannabis Sativa Wild Earth Naturals Kush Proforma Revenue $- $3,454 $3,697 $7,151 Cost of revenue - 2,425 - 2,425 Gross profit - 1,029 3,697 4,726 Impairment of goodwill 13,070,346 - - 13,070,346 Research and development expense - 3,712 - 3,712 General and adminstrative expense 819,408 353,885 765,925 1,939,218 Other (income) and expense Gain on sale of patent - (49,512) - (49,512) Interest expense 6,939 19,558 - 26,497 Loss from continued operations (13,896,693) (326,614) (762,228) (14,985,535) Net Loss $(13,896,693) $(326,614) $(762,228) $(14,985,535) Development Stage Activities and Operations: Wild Earth has been in its initial stages of formation and for the year ended December 31, 2015 had minimal revenues. A development stage activity is one in which all efforts are devoted substantially to establishing a new business and even if planned principal operations have commenced, revenues are insignificant. Cash and Cash Equivalents: For financial accounting purposes, cash and cash equivalents are considered to be all highly liquid investments purchased with an initial maturity of three (3) months or less. Accounts Receivable: We estimate credit loss reserves for accounts receivable on an individual receivable basis. A specific impairment allowance reserve is established based on expected future cash flows and the financial condition of the debtor. We charge off customer balances in part or in full when it is more likely than not that we will not collect that amount of the balance due. We consider any balance unpaid after the contract payment period to be past due. At December 31, 2015 the company has established an allowance for doubtful accounts of $-0-. Inventory: The Company calculates inventory using the average cost method to value inventory. Inventory cost includes those costs directly attributable to the product before sale. Inventory consists of salves, ointments, lotions, creams and balms and is carried at the lower of cost or market, using first-in, first-out method (FIFO) of determining cost. At December 31, 2015 there was $24,044 in raw materials and $893 in finished goods inventory. At December 31, 2014 the Company has $11,144 in raw materials and $6,693 in finished goods inventory Fair Value of Financial Instruments: The estimated fair values for financial instruments are determined at discrete points in time based on relevant market information. These estimates involve uncertainties and cannot be determined with precision. The carrying amounts of accounts payable, accrued liabilities, and notes payable approximate fair value given their short term nature or effective interest rates. Earnings per Share: Basic earnings per share is computed by dividing income available to common shareholders by the weighted average number of common shares outstanding for the period and contains no dilutive securities. Diluted earnings per share reflect the potential dilution of securities that could share in the earnings of an entity. As of December 31, 2015 and 2014, the Company has no outstanding potentially dilutive securities. Revenue Recognition: The Company recognizes revenue from product sales or services rendered when the following four revenue recognition criteria are met: persuasive evidence of an arrangement exists, delivery has occurred or services have been rendered, the selling price is fixed or determinable, and collectability is reasonably assured. Use of Estimates: The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Digital Currencies Translations and Re-measurements The Company accounts for digital currencies, which it considers to be an operating asset, at their initial cost and subsequently re-measures the carrying amounts of digital currencies it owns at each reporting date based on their current fair value. The changes in the fair value of digital currencies are included as a component of income or loss from operations. The Company currently classifies digital currencies as a current asset. The Company obtains the equivalency rate of bitcoins to USD from Coindesk. The equivalency rate obtained from Coindesk represents a generally well recognized quoted price in an active market for bitcoins, which market and related database are accessible to the Company on an ongoing basis. The Bitcoin Price Index was $473.06 as of December 31, 2015. Fixed Assets: Property and equipment are recorded at cost. Depreciation is provided for on the straight-line method over the estimated useful lives of the assets. The average lives range from three (3) to seven (7) years. Leasehold improvements are amortized on the straight-line method over the lesser of the lease term or the useful life. Maintenance and repairs that neither materially add to the value of the property nor appreciably prolong its life are charged to expense as incurred. Betterments or renewals are capitalized when incurred. For the year ended December 31, 2015, depreciation expense was $1,196, of which $708 was recorded in General and Administrative expense and $488 was recorded in Discontinued Operations. For the year ended December 31, 2014, depreciation expense was $2,343 of which $2,294 was recorded in General and Administrative expense and $49 was recorded in Cost of Revenues. Intangible Assets: Intangible assets are comprised of patents, trademarks, the Company's "CBDS.com" website domain and intellectual property rights. The patent is being amortized using the straight-line method over its economic life, which is estimated to be twenty (20) years. The trademark, which is still in the application phase, is expected to have an indefinite useful life. The CBDS.com website is expected to have an indefinite useful life. The intellectual property rights are being amortized using the straight-line month over its economic life, which is estimated to be (20) years. For the year ended December 31, 2015 amortization expense was $102,418 of which $25,901 was included in General and Administrative expense and $76,517 was recorded in Discontinued Operations. For the year ended December 31, 2014 amortization expense was $76,537. Income Taxes: The Company adopted the provisions of ASC 740-10, Accounting for Uncertainty in Income Taxes, on January 1, 2007, with no material impact on the accompanying financial statements. The Company files income tax returns in the U.S. federal jurisdiction, and the State of Utah. The Company is subject to federal, state and local income tax examinations by tax authorities for approximately the past three years or in some instances longer periods. Deferred income taxes are provided using the asset and liability method, whereby deferred tax assets are recognized for deductible temporary differences and operating loss and tax credit carryforwards and deferred tax liabilities are recognized for taxable temporary differences. Temporary differences are the differences between the reported amounts of assets and liabilities and their tax basis. Net deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the net deferred tax assets will not be realized. Deferred tax assets and liabilities are adjusted for the effects of the changes n tax laws and rates at the date of enactment. When tax returns are filed, it is highly certain that some positions taken would be sustained upon examination by the taxing authorities, while others are subject to uncertainty about the merits of the position taken or the amount of the position that would be ultimately sustained. The benefit of a tax position is recognized in the financial statements in, including the resolution of appeals or litigation processes, the period during which, based on all available evidence, management believes it is more likely than not that the position will be sustained upon examination, including resolution of appeals or litigation processes, if any. Tax positions taken are not offset or aggregated with other positions. Tax positions that meet the more-likely-than-not recognition threshold are measured as the largest amount of tax benefit that is more than 50 percent likely of being realized upon settlement with the applicable taxing authority. The portion of the benefits associated with tax positions taken that exceeds the amount measured, if any, is reflected as a liability for unrecognized tax benefits in the accompanying balance sheet along with any associated interest and penalties that would be payable to the taxing authorities upon examination. Interest and penalties associated with unrecognized tax benefits, if any, are classified as additional income taxes in the statement of operations. Currently there are not penalties or interest. Pending Accounting Pronouncements: There have been no recent accounting pronouncements issued which are expected to have a material effect on the Company's financial statements.

2. Eden Holdings Llc

2. Eden Holdings Llc	12 Months Ended
	Dec. 31, 2015
Notes
2. Eden Holdings Llc	2. Eden Holdings LLC During the quarter ended September 30, 2014, the Company created Eden Holdings LLC. The purpose of the entity is to hold the intellectual property of Cannabis Sativa, Inc. As of December 31, 2015 there has been no activity in the LLC.

3. Available-for-sale Securitie

3. Available-for-sale Securities	12 Months Ended
	Dec. 31, 2015
Notes
3. Available-for-sale Securities	3. Available-for-Sale Securities On January 10, 2014 the Company received 10,835 shares of BioAdaptives, Inc. as a result of Kush's holdings in Hemp, Inc. The shares were received when Hemp, Inc. completed a spin-off of BioAdaptives, Inc. Each 923 shares of Hemp, Inc. received 1 share of BioAdaptives, Inc. At the time of the spin-off, Kush, Inc. was the owner of 10,000,000 shares of Hemp, Inc. common stock. This resulted in Kush receiving 10,835 shares of BioAdaptives, Inc. At December 31, 2015 the market price of BioAdaptives, Inc. was $.45 per share resulting in a value of $4,876. This investment was included in the spin-off of Kush therefore the value is $-0- on the Company's balance sheet at December 31, 2015. The following is a summary of the Company's available-for-sale securities at December 31, 2015: Amortized Cost Gross Unrealized Gains Gross Unrealized Losses Fair Value (Net Carrying Amount) Accumulated Other Comprehensive Income Equity Securities $- $- $- $- $- Total Available-for-Sale Securities $- $- $- $- $- The following is a summary of the Company's available-for-sale securities at December 31, 2014: Amortized Cost Gross Unrealized Gains Gross Unrealized Losses Fair Value (Net Carrying Amount) Accumulated Other Comprehensive Income Equity Securities $- $4,876 $- $4,876 $4,876 Total Available-for-Sale Securities $- $4,876 $- $4,876 $4,876

4. Fair Value Measurements

4. Fair Value Measurements	12 Months Ended
	Dec. 31, 2015
Notes
4. Fair Value Measurements	4. Fair Value Measurements We adopted ASC Topic 820 for financial instruments measured at fair value on a recurring basis. ASC Topic 820 defines fair value, establishes a framework for measuring fair value in accordance with accounting principles generally accepted in the United States and expands disclosures about fair value measurements. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. ASC Topic 820 establishes a three-tier fair value hierarchy which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include: · Level 1, defined as observable inputs such as quoted prices for identical instruments in active markets; · Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and · Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. The estimated fair values for financial instruments are determined at discrete points in time based on relevant market information. These estimates involve uncertainties and cannot be determined with precision. The carrying amounts of accounts receivable, inventory, notes payable, accounts payable, accrued liabilities approximate fair value given their short term nature or effective interest rates. We measure certain financial instruments at fair value on a recurring basis. As of December 31, 2015, assets and liabilities measured at fair value on a recurring basis were as follows: Total Level 1 Level 2 Level 3 Assets: Digital Currency $5,203 $5,203 $- $- Total assets measured at fair value $5,203 $5,203 $- $- Liabilities: $- $- $- $- Total liabilities measured at fair value $- $- $- $- As of December 31, 2014, assets and liabilities measured at fair value on a recurring basis were as follows: Total Level 1 Level 2 Level 3 Assets: Available-for-sale securities $4,876 $4,876 $- $- Total assets measured at fair value $4,876 $4,876 $- $- Liabilities: $- $- $- $- Total liabilities measured at fair value $- $- $- $-

5. Hempcoins

5. Hempcoins	12 Months Ended
	Dec. 31, 2015
Notes
5. Hempcoins	5. Hempcoins At December 31, 2015, the Company has possession of 110,000,000 hempcoins. Hempcoins are reported as digital currency. Every 10 hempcoins are backed by 1 share of Rocky Mountain Inc (RMTN). At December 31, 2015 and 2014 the value of hempcoins was $5,204 and $-0-, respectively, computed by converting to bitcoin (See Note 1).

6. Investment in Joint Venture

6. Investment in Joint Venture	12 Months Ended
	Dec. 31, 2015
Notes
6. Investment in Joint Venture	6. Investment in Joint Venture On September 11, 2015 Hi-Brands International, Inc. a wholly owned subsidiary of the Company entered into a joint venture agreement with I.D.E.A – International Dental Emergency Alliance, LLC. (IDEA). IDEA is the developer of a pharmacy discount card distribution and online marketing platform with access to a network of approximately 60,000 participating pharmacies through a virtual and/or physical discount card. IDEA and the Company wish to develop, market and distribute a private label discount card and system under its proprietary brands and/or trademarks to the general public and to sub-distributors. The Company and IDEA have agreed to share all revenues 50/50 and IDEA has agreed to pay the Company 50% of a $.50 shared fee per claim. The claim fee will increase based upon a set schedule as claims increase. The term of the agreement is for 3 years, but can be renewed for an additional three (3) year term periods. IDEA is charging the Company $35,000 as a set up fee and as part of the agreement IDEA is expected to generate 25,000 members/cardholders in the first year.

7. Fixed Assets and Intangibles

7. Fixed Assets and Intangibles	12 Months Ended
	Dec. 31, 2015
Notes
7. Fixed Assets and Intangibles	7. Fixed Assets and Intangibles Property and Equipment consisted December 31, December 31, 2015 2014 Furniture and Equipment $8,108 $8,108 Leasehold Improvements 2,500 2,500 10,608 10,608 Less: Accumulated Depreciation 6,104 3,571 Net Property and Equipment $4,504 $7,037 Intangible assets consisted December 31, December 31, 2015 2014 CBDS.com website (Cannabis Sativa) $13,999 $13,999 Intellectual Property Rights (Cannabis Sativa) 2,902,660 - Intellectual Property Rights (Kush) - 3,060,000 Patents and Trademarks (Cannabis Sativa) 8,938 - Patents and Trademarks (Kush) - 10,136 Patents and Trademarks (Wild Earth) 4,425 4,425 2,930,022 3,088,560 Less: Accumulated Amortization 25,901 89,268 Net Intangible Assets $2,904,121 $2,999,292 Upon purchase of Kush, Cannabis Sativa owns an approximately 90% membership inter est ,

8. Due To Related Parties

8. Due To Related Parties	12 Months Ended
	Dec. 31, 2015
Notes
8. Due To Related Parties	8. Due to Related Parties During the year ended December 31, 2015 the Company received additional short-term advances from related parties and officers of the Company to cover operating expenses in the amount of $362,202. As of December 31, 2015, net advances to the Company were $27,427. Previous debt was paid through issuance of preferred stock. These advances were non-interest bearing in nature. The Company has imputed interest on these sums at the rate of 5% per annum and has recorded interest expense related to these balances in the amount of $25,978. Because the related parties do not expect the imputed interest to be repaid, the interest has been recorded as a contribution of capital during the year ended December 31, 2015. Also included in accrued expenses at December 31, 2015 was $13,000 to the CFO for accrued payroll. Kush, a wholly-owned subsidiary of the Company, is a party to three individual license agreements with Steve Kubby. Pursuant to the license agreements Kush owed a total of $3,060,000 in license fees to Mr. Kubby at various dates. On June 30, 2015, Kush sold $3,060,000 of its originally priced Intellectual Property to CBDS, net of $165,750 of accumulated amortization for a gross sales price of $2,894,250 for which CBDS assumed a liability to Steve Kubby, the licensor of the intellectual property, of $2,890,499. Additionally, CBDS received Kush's interest in K-Pal, which is the holder of the intellectual property in the amount of $8,938, less a non-controlling interest of $894. Correspondingly, on Cannabis Sativa's books as of June 30, 2015, the Long Term Investment in K-Pal was booked at $8,938 and the non-controlling interest of $894 was recognized as a reduction of equity. The acquisition of intellectual property assets was also booked for $3,060,000 which had accumulated amortization of $165,750 and based on agreement with Steve Kubby, all liability to him was retired in exchange for 1,500,000 shares of Cannabis Sativa Preferred Stock at par value of $.001, resulting in a credit to the Preferred Stock account of $1,500, with the balance to Paid in Capital of $2,888,999. As part of the spinoff transaction with Kush (as described in Note 10), the 1,500,000 preferred shares were returned to the Company and the credit to Preferred Stock account of $1,500 has been reversed as of December 31, 2015. On September 30, 2015, an agreement was entered into by the Company to exchange $857,170 in debt held by three related parties for 428,585 shares of the Company's preferred stock based on the common share closing price on September 29, 2015 of $2 per share. The preferred shares have no other preferences other than upon liquidation, have no voting rights, and will be convertible into common stock on a one to one basis. The agreements contain a contingency clause that should the common share price drop below $2 per share between October to December, 2015, then the average of the daily high and low price over those subsequent 90 days will be taken, and additional preferred shares will be issued to equal that average 90 day price. At December 31, 2015, the Company has recorded 303,433 preferred shares due to these related parties based upon the 90 day market price of $1.1709769. Therefore, $303 was recorded in additional paid in capital and stock payable at December 31, 2015.

9. Common Stock

9. Common Stock	12 Months Ended
	Dec. 31, 2015
Notes
9. Common Stock	9. Common Stock On January 1, 2015, the Company's board of directors authorized the issuance of 100,000 shares of its common stock to one of its officers. The value of the shares on the date of issuance was $690,000. As of December 31, 2015, the Company has recognized $690,000 in compensation expense related to this transaction. On January 1, 2015, the Company's board of directors authorized the issuance of 10,000 shares of its common stock to each of its seven board of directors for each year of service. The Company issued 2,500 shares to each board member retroactive to the fourth quarter of 2014 in addition to 10,000 each for 2015 for a total of 12,500 shares each. The Company had recorded a liability in the amount of $120,750 related to the retroactive issuance in its December 31, 2014 financial statements. The Company recorded $483,000 in professional fees on its statement of operations for the year ended December 31, 2015. On January 1, 2015, the Company's board of directors authorized the issuance of 35,000 shares of its common stock to one of its officers for retroactive compensation in 2014. The value of the shares was determined to be $241,500 based on the trading price of the stock on the date of authorization. The Company had recorded a liability in the same amount in its balance sheet dated December 31, 2014. These shares were issued during the first quarter of 2015. On January 7, 2015, the Company's board of directors authorized the issuance of 500,000 shares of its common stock to a consulting group for services to be provided during the year ended December 31, 2015. The value of the issuance was determined to be $3,500,000 based on the market value of the Company's common stock on the date of issuance. The Company recorded $2,625,000 in consulting expense during the year ended December 31, 2015 related to this transaction. January 30, 2015, the Company's board of directors authorized the issuance of 200,000 shares to two consultants for services to be provided during the year ended December 31, 2015. The value of the issuance was determined to be $1,640,000. The Company has recorded $1,640,000 in consulting expense during the year ended December 31, 2015 related to this transaction. During the period ended September 30, 2015, the Company's board of directors authorized the issuance of 80,000 shares to two consultants for services to be provided during the year ended December 31, 2015. The value of the issuance was determined to be $84,800. The Company has recorded $84,800 in consulting expense during the year ended December 31, 2015 related to this transaction. During the period ended September 30, 2015, the Company's board of directors authorized the issuance of 5,000 shares to the Company's eighth (8 th On October 6, 2015, the Company's board of directors authorized the issuance of 2,500 shares to the Company's eighth (8 th

10. Preferred Stock

10. Preferred Stock	12 Months Ended
	Dec. 31, 2015
Notes
10. Preferred Stock	10. Preferred Stock There are 5,000,000 preferred shares authorized with a par value of $.001. During 2015, the Company issued 1,500,000 preferred shares to Steve Kubby as described in Note 8. By agreement with Steve Kubby, all liability to him was retired in exchange for the 1,500,000 preferred shares. Then, as part of that agreement involving the Company's spinoff of Kush, the 1,500,000 preferred shares owned by Kubby were determined to have a value equivalent to 17,289,304 shares of the Company's common. The effective result of this was that Mr. Kubby joined pro rata with other Company shareholders in receiving 4.3155 Kush shares for every share of equivalent Company common stock that was held as of the August 25, 2015 record date. In the case of Mr. Kubby, the amount of his ownership of Company common stock and the value ascribed to his ownership of Company preferred stock, together, gave him approximately 51% ownership of Kush's common stock post spinoff (after also giving effect to newly issued Kush shares representing 9% of Kush going to the Company in exchange for 1,250,000 shares of the Company's common stock- see Note 15). As part of this spinoff transaction, the 1,500,000 preferred shares were returned to the Company. Dividends No Liquidation Preference Voting Rights Conversion No Preemptive Rights Effect of Stock Split

11. Hi Brands International Inc

11. Hi Brands International Inc. - Centuria Foods Agreement	12 Months Ended
	Dec. 31, 2015
Notes
11. Hi Brands International Inc. - Centuria Foods Agreement	11. Hi Brands International Inc. – Centuria Foods Agreement On February 6, 2015, the Company formed Hi Brands International Inc., a Nevada Corporation and wholly owned subsidiary of Cannabis Sativa, Inc. On February 25, 2015, the Company through its wholly owned subsidiary Hi Brands International, Inc., (jointly referred to hereinafter as "Cannabis Sativa"), entered into a Purchase, Supply and Joint Venture Agreement (the "Agreement"), with Centuria Natural Foods, Inc. ("Centuria") whereby Cannabis Sativa will market Centuria's proprietary CBD (Cannabidiol) Rich Hemp Oil products (the "Products"). The initial term of the Agreement is one year which may be renewed for additional one year periods upon the mutual agreement of the parties. Within the first 90 days of the initial term of the Agreement, Cannabis Sativa shall order at least 5,000 units of Product. Thereafter, Cannabis Sativa shall order at least 5,000 units of Product per month with the additional requirement that Cannabis Sativa order a minimum of 55,000 units of Product during the first 12 months of the Agreement. Fifty percent of all gross revenue generated by the sale of the Products will be paid to Cannabis Sativa and fifty percent will be paid to Centuria. As of December 31, 2015, there has not been any activity in Hi Brands International Inc., other than the execution of the above agreement. The Company has not ordered any product under this agreement as of December 31, 2015.

12. Going Concern Consideration

12. Going Concern Considerations	12 Months Ended
	Dec. 31, 2015
Notes
12. Going Concern Considerations	12. Going Concern Considerations The accompanying financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America, which contemplate continuation of the Company as a going concern. The Company has incurred net losses since inception. As reported in the financial statements, the Company has an accumulated deficit of $54,093,099 which raises substantial doubt about the Company's ability to continue as a going concern. The ability of the Company to continue as a going concern is dependent on its ability to raise adequate capital to fund operating losses until it is able to engage in profitable business operations. To the extent financing is not available, the Company may not be able to, or may be delayed in, developing its services and meeting its obligations. The Company will continue to evaluate its projected expenditures relative to its available cash and to evaluate additional means of financing in order to satisfy its working capital and other cash requirements. The accompanying financial statements do not reflect any adjustments that might result from the outcome of these uncertainties.

13. Commitments and Contingenci

13. Commitments and Contingencies	12 Months Ended
	Dec. 31, 2015
Notes
13. Commitments and Contingencies	13. Commitments and Contingencies The Company leases an office and warehouse facility in Mesquite, Nevada that serves as the principal executive offices and provides manufacturing and warehouse space. The leased space consists of 908 square feet. The building in which our space is located is in foreclosure therefore the Company rents from the bank that controls the property on a month to month basis. Rent expense is $771.80 per month. Rent expense for the years ended December 31, 2015 and 2014 were $8,490 and $6,217, respectively.

14. Legal Proceedings

14. Legal Proceedings	12 Months Ended
	Dec. 31, 2015
Notes
14. Legal Proceedings	14. Legal Proceedings On August 26, 2015 the Company filed a complaint in the District Court of Clark County, Nevada against 3 (three) individuals and Colonial Stock Transfer Company, Inc., a Utah Corporation, seeking declaratory relief for the cancelation of common shares of the Company, issued in connection with a consulting agreement. The complaint alleges a breach of the consulting agreement by the defendants. In addition to seeking a cancellation of shares, the complaint seeks general, consequential and punitive damages and costs in unspecified amounts. At December 31, 2015 this complaint was still in negotiation.

15. Spin Off

15. Spin Off	12 Months Ended
	Dec. 31, 2015
Notes
15. Spin Off	15. Spin Off On November 2, 2015 the Company approved the spin-off of its wholly owned subsidiary Kush Inc. In this transaction every shareholder of CBDS will receive 4.3155 Kush shares for every share of CBDS stock that they held as of August 25, 2015, the record date. As part of the spinoff agreement with Kush and its major shareholder Steve Kubby, CBDS would exchange, post spinoff, 500,000 shares of its common stock for 9% ownership of Kush represented by 14,260,436 newly issued Kush shares. It was subsequently agreed in negotiations with Kush and its major shareholder Steve Kubby that instead of the issuance of 500,000 shares of CBDS common stock for 9% ownership of Kush in which Kush would then participate in the 1.5 share forward stock dividend, that Kush would alternatively be issued 1.25 million shares of the Company's common stock for 9% ownership of Kush after the record date of the 1.5 share forward stock dividend and that accordingly, such CBDS shares received by Kush would not participate in the 1.5 share forward stock dividend. The Company will be receiving an additional 14,260,436 shares of Kush common stock to retain its 9% interest in Kush. As of December 31, 2015, the spin-off had occurred and was effective on the books and records of the Company, however the actual stock has yet to be issued.

16. Subsequent Events

16. Subsequent Events	12 Months Ended
	Dec. 31, 2015
Notes
16. Subsequent Events	16. Subsequent Events Shareholders of Cannabis Sativa, Inc. received 4.32 shares of Kush for every share of ownership of common stock in the Company as a shareholder dividend on August 25, 2015. This was completed on November 2, 2015, but shares have not yet been issued as of December 31, 2015. In accordance with the Kush spin off agreement, the Company is to issue 1,250,000 shares of its common shares to Kush. In return, for the 9% equity in Kush the Company shall receive 14,260,436 shares of Kush. On November 2, 2015, the Company announced that it will pay a special stock dividend of 1.5 restricted common shares for each share held as of the record date of November 16, 2015. The holding period for these shares is 6 months from the issue date to shareholders of record. The Company has also submitted its application to be listed on NASDAQ. Subsequent to December 31, 2015, the Company issued 30,000 shares of its common stock to consultants.

1. Summary of Significant Acc23

1. Summary of Significant Accounting Policies and Use of Estimates (Policies)	12 Months Ended
	Dec. 31, 2015
Policies
Cash and Cash Equivalents	Cash and Cash Equivalents: For financial accounting purposes, cash and cash equivalents are considered to be all highly liquid investments purchased with an initial maturity of three (3) months or less.
Accounts Receivable	Accounts Receivable: We estimate credit loss reserves for accounts receivable on an individual receivable basis. A specific impairment allowance reserve is established based on expected future cash flows and the financial condition of the debtor. We charge off customer balances in part or in full when it is more likely than not that we will not collect that amount of the balance due. We consider any balance unpaid after the contract payment period to be past due. At December 31, 2015 the company has established an allowance for doubtful accounts of $-0-.
Inventory	Inventory: The Company calculates inventory using the average cost method to value inventory. Inventory cost includes those costs directly attributable to the product before sale. Inventory consists of salves, ointments, lotions, creams and balms and is carried at the lower of cost or market, using first-in, first-out method (FIFO) of determining cost. At December 31, 2015 there was $24,044 in raw materials and $893 in finished goods inventory. At December 31, 2014 the Company has $11,144 in raw materials and $6,693 in finished goods inventory
Fair Value of Financial Instruments:	Fair Value of Financial Instruments: The estimated fair values for financial instruments are determined at discrete points in time based on relevant market information. These estimates involve uncertainties and cannot be determined with precision. The carrying amounts of accounts payable, accrued liabilities, and notes payable approximate fair value given their short term nature or effective interest rates.
Earnings Per Share:	Earnings per Share: Basic earnings per share is computed by dividing income available to common shareholders by the weighted average number of common shares outstanding for the period and contains no dilutive securities. Diluted earnings per share reflect the potential dilution of securities that could share in the earnings of an entity. As of December 31, 2015 and 2014, the Company has no outstanding potentially dilutive securities.
Revenue Recognition:	Revenue Recognition: The Company recognizes revenue from product sales or services rendered when the following four revenue recognition criteria are met: persuasive evidence of an arrangement exists, delivery has occurred or services have been rendered, the selling price is fixed or determinable, and collectability is reasonably assured.
Use of Estimates	Use of Estimates: The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.
Digital Currencies Translations and Re-measurements	Digital Currencies Translations and Re-measurements The Company accounts for digital currencies, which it considers to be an operating asset, at their initial cost and subsequently re-measures the carrying amounts of digital currencies it owns at each reporting date based on their current fair value. The changes in the fair value of digital currencies are included as a component of income or loss from operations. The Company currently classifies digital currencies as a current asset. The Company obtains the equivalency rate of bitcoins to USD from Coindesk. The equivalency rate obtained from Coindesk represents a generally well recognized quoted price in an active market for bitcoins, which market and related database are accessible to the Company on an ongoing basis. The Bitcoin Price Index was $473.06 as of December 31, 2015.
Fixed Assets:	Fixed Assets: Property and equipment are recorded at cost. Depreciation is provided for on the straight-line method over the estimated useful lives of the assets. The average lives range from three (3) to seven (7) years. Leasehold improvements are amortized on the straight-line method over the lesser of the lease term or the useful life. Maintenance and repairs that neither materially add to the value of the property nor appreciably prolong its life are charged to expense as incurred. Betterments or renewals are capitalized when incurred. For the year ended December 31, 2015, depreciation expense was $1,196, of which $708 was recorded in General and Administrative expense and $488 was recorded in Discontinued Operations. For the year ended December 31, 2014, depreciation expense was $2,343 of which $2,294 was recorded in General and Administrative expense and $49 was recorded in Cost of Revenues.
Intangible Assets:	Intangible Assets: Intangible assets are comprised of patents, trademarks, the Company's "CBDS.com" website domain and intellectual property rights. The patent is being amortized using the straight-line method over its economic life, which is estimated to be twenty (20) years. The trademark, which is still in the application phase, is expected to have an indefinite useful life. The CBDS.com website is expected to have an indefinite useful life. The intellectual property rights are being amortized using the straight-line month over its economic life, which is estimated to be (20) years. For the year ended December 31, 2015 amortization expense was $102,418 of which $25,901 was included in General and Administrative expense and $76,517 was recorded in Discontinued Operations. For the year ended December 31, 2014 amortization expense was $76,537.
Income Taxes:	Income Taxes: The Company adopted the provisions of ASC 740-10, Accounting for Uncertainty in Income Taxes, on January 1, 2007, with no material impact on the accompanying financial statements. The Company files income tax returns in the U.S. federal jurisdiction, and the State of Utah. The Company is subject to federal, state and local income tax examinations by tax authorities for approximately the past three years or in some instances longer periods. Deferred income taxes are provided using the asset and liability method, whereby deferred tax assets are recognized for deductible temporary differences and operating loss and tax credit carryforwards and deferred tax liabilities are recognized for taxable temporary differences. Temporary differences are the differences between the reported amounts of assets and liabilities and their tax basis. Net deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the net deferred tax assets will not be realized. Deferred tax assets and liabilities are adjusted for the effects of the changes n tax laws and rates at the date of enactment. When tax returns are filed, it is highly certain that some positions taken would be sustained upon examination by the taxing authorities, while others are subject to uncertainty about the merits of the position taken or the amount of the position that would be ultimately sustained. The benefit of a tax position is recognized in the financial statements in, including the resolution of appeals or litigation processes, the period during which, based on all available evidence, management believes it is more likely than not that the position will be sustained upon examination, including resolution of appeals or litigation processes, if any. Tax positions taken are not offset or aggregated with other positions. Tax positions that meet the more-likely-than-not recognition threshold are measured as the largest amount of tax benefit that is more than 50 percent likely of being realized upon settlement with the applicable taxing authority. The portion of the benefits associated with tax positions taken that exceeds the amount measured, if any, is reflected as a liability for unrecognized tax benefits in the accompanying balance sheet along with any associated interest and penalties that would be payable to the taxing authorities upon examination. Interest and penalties associated with unrecognized tax benefits, if any, are classified as additional income taxes in the statement of operations. Currently there are not penalties or interest.
Pending Accounting Pronouncements:	Pending Accounting Pronouncements: There have been no recent accounting pronouncements issued which are expected to have a material effect on the Company's financial statements.

1. Summary of Significant Acc24

1. Summary of Significant Accounting Policies and Use of Estimates (Tables)	12 Months Ended
	Dec. 31, 2015
Tables/Schedules
Schedule of Pro Forma Condensed Combined Statement of Operations	Cannabis Sativa Wild Earth Naturals Kush Proforma Revenue $- $3,454 $3,697 $7,151 Cost of revenue - 2,425 - 2,425 Gross profit - 1,029 3,697 4,726 Impairment of goodwill 13,070,346 - - 13,070,346 Research and development expense - 3,712 - 3,712 General and adminstrative expense 819,408 353,885 765,925 1,939,218 Other (income) and expense Gain on sale of patent - (49,512) - (49,512) Interest expense 6,939 19,558 - 26,497 Loss from continued operations (13,896,693) (326,614) (762,228) (14,985,535) Net Loss $(13,896,693) $(326,614) $(762,228) $(14,985,535)

3. Available-for-sale Securit25

3. Available-for-sale Securities (Tables)	12 Months Ended
	Dec. 31, 2015
Tables/Schedules
Schedule of Available-for-sale Securities	The following is a summary of the Company's available-for-sale securities at December 31, 2015: Amortized Cost Gross Unrealized Gains Gross Unrealized Losses Fair Value (Net Carrying Amount) Accumulated Other Comprehensive Income Equity Securities $- $- $- $- $- Total Available-for-Sale Securities $- $- $- $- $- The following is a summary of the Company's available-for-sale securities at December 31, 2014: Amortized Cost Gross Unrealized Gains Gross Unrealized Losses Fair Value (Net Carrying Amount) Accumulated Other Comprehensive Income Equity Securities $- $4,876 $- $4,876 $4,876 Total Available-for-Sale Securities $- $4,876 $- $4,876 $4,876

4. Fair Value Measurements (Tab

4. Fair Value Measurements (Tables)	12 Months Ended
	Dec. 31, 2015
Tables/Schedules
Schedule of Assets and Liabilities Measured at Fair Value on a Recurring Basis	As of December 31, 2015, assets and liabilities measured at fair value on a recurring basis were as follows: Total Level 1 Level 2 Level 3 Assets: Digital Currency $5,203 $5,203 $- $- Total assets measured at fair value $5,203 $5,203 $- $- Liabilities: $- $- $- $- Total liabilities measured at fair value $- $- $- $- As of December 31, 2014, assets and liabilities measured at fair value on a recurring basis were as follows: Total Level 1 Level 2 Level 3 Assets: Available-for-sale securities $4,876 $4,876 $- $- Total assets measured at fair value $4,876 $4,876 $- $- Liabilities: $- $- $- $- Total liabilities measured at fair value $- $- $- $-

7. Fixed Assets and Intangibl27

7. Fixed Assets and Intangibles (Tables)	12 Months Ended
	Dec. 31, 2015
Tables/Schedules
Schedule of Property and Equipment	Property and Equipment consisted December 31, December 31, 2015 2014 Furniture and Equipment $8,108 $8,108 Leasehold Improvements 2,500 2,500 10,608 10,608 Less: Accumulated Depreciation 6,104 3,571 Net Property and Equipment $4,504 $7,037
Schedule of Intangible Assets	Intangible assets consisted December 31, December 31, 2015 2014 CBDS.com website (Cannabis Sativa) $13,999 $13,999 Intellectual Property Rights (Cannabis Sativa) 2,902,660 - Intellectual Property Rights (Kush) - 3,060,000 Patents and Trademarks (Cannabis Sativa) 8,938 - Patents and Trademarks (Kush) - 10,136 Patents and Trademarks (Wild Earth) 4,425 4,425 2,930,022 3,088,560 Less: Accumulated Amortization 25,901 89,268 Net Intangible Assets $2,904,121 $2,999,292

1. Summary of Significant Acc28

1. Summary of Significant Accounting Policies and Use of Estimates (Details)	12 Months Ended
	Dec. 31, 2015
Details
Entity Incorporation, Date of Incorporation	Nov. 5, 2004

1. Summary of Significant Acc29

1. Summary of Significant Accounting Policies and Use of Estimates: Schedule of Pro Forma Condensed Combined Statement of Operations (Details) - USD ($)	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
Revenue	$ 11,610	$ 7,151
Cost of revenue	5,787	2,425
Gross profit	5,823	4,726
Impairment of goodwill		13,070,346
Research and development expense		3,712
General and administrative expense	7,303,371	1,323,415
Other (income) and expense
Gain on sale of patent		49,512
Interest expense	26,871	26,497
Net Loss	(7,432,859)	$ (14,369,732)
Pro Forma
Revenue	7,151
Cost of revenue	2,425
Gross profit	4,726
Impairment of goodwill	13,070,346
Research and development expense	3,712
General and administrative expense	1,939,218
Other (income) and expense
Gain on sale of patent	(49,512)
Interest expense	26,497
Loss from continued operations	(14,985,535)
Net Loss	(14,985,535)
Wild Earth Naturals Inc
Revenue	3,454
Cost of revenue	2,425
Gross profit	1,029
Impairment of goodwill	0
Research and development expense	3,712
General and administrative expense	353,885
Other (income) and expense
Gain on sale of patent	(49,512)
Interest expense	19,558
Loss from continued operations	(326,614)
Net Loss	(326,614)
Kush
Revenue	3,697
Cost of revenue	0
Gross profit	3,697
Impairment of goodwill	0
Research and development expense	0
General and administrative expense	765,925
Other (income) and expense
Gain on sale of patent	0
Interest expense	0
Loss from continued operations	(762,228)
Net Loss	(762,228)
Cannabis Sativa
Revenue	0
Cost of revenue	0
Gross profit	0
Impairment of goodwill	13,070,346
Research and development expense	0
General and administrative expense	819,408
Other (income) and expense
Gain on sale of patent	0
Interest expense	6,939
Loss from continued operations	(13,896,693)
Net Loss	$ (13,896,693)

1. Summary of Significant Acc30

1. Summary of Significant Accounting Policies and Use of Estimates: Accounts Receivable (Details) - USD ($)	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
Details
Allowance for doubtful accounts	$ 0	$ 3,697

1. Summary of Significant Acc31

1. Summary of Significant Accounting Policies and Use of Estimates: Inventory (Details)	Dec. 31, 2015USD ($)
Details
Inventory, Raw Materials	$ 11,144
Inventory, Finished Goods	$ 6,693

1. Summary of Significant Acc32

1. Summary of Significant Accounting Policies and Use of Estimates: Earnings Per Share (Details) - shares	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
Details
Potentially dilutive securities outstanding	0	0

1. Summary of Significant Acc33

1. Summary of Significant Accounting Policies and Use of Estimates: Digital Currencies Translations and Re-measurements (Details)	Dec. 31, 2015USD ($)
Details
Bitcoin Price Index	$ 473.06

1. Summary of Significant Acc34

1. Summary of Significant Accounting Policies and Use of Estimates: Fixed Assets (Details) - USD ($)	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
Depreciation	$ 1,196	$ 2,343
General and Administrative Expense
Depreciation	708	2,294
Loss From Discontinued Operations
Depreciation	$ 488
Cost of Sales
Depreciation		$ 49

1. Summary of Significant Acc35

1. Summary of Significant Accounting Policies and Use of Estimates: Intangible Assets (Details) - USD ($)	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
Amortization of Intangible Assets	$ 102,418	$ 76,537
General and Administrative Expense
Amortization of Intangible Assets	25,901
Loss From Discontinued Operations
Amortization of Intangible Assets	$ 76,517
Intellectual Property
Finite-Lived Intangible Asset, Useful Life	20 years

3. Available-for-sale Securit36

3. Available-for-sale Securities (Details) - USD ($)	Dec. 31, 2015	Sep. 29, 2015	Jan. 10, 2014
Share Price	$ 1.1709769	$ 2
Investment Owned, Value	$ 5,203
BioAdaptives, Inc.
Additional Kush shares to retain			10,835
Share Price	$ 0.45
Investment Owned, Value	$ 4,876
Hemp, Inc.
Additional Kush shares to retain			10,000,000

3. Available-for-sale Securit37

3. Available-for-sale Securities: Schedule of Available-for-sale Securities (Details) - USD ($)	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
Details
Equity Securities, Amortized Cost	$ 0	$ 0
Equity Securities, Gross Unrealized Gains	0	4,876
Equity Securities, Gross Unrealized Losses	0	0
Equity Securities, Fair Value (Net Carrying Amount)	0	4,876
Total Available-for-Sale Securities, Amortized Cost	0	0
Total Available-for-Sale Securities, Gross Unrealized Gains	0	4,876
Total Available-for-Sale Securities, Gross Unrealized Losses	0	0
Total Available-for-Sale Securities, Fair Value (Net Carrying Amount)	0	4,876
Total Available-for-Sale Securities, Accumulated Other Comprehensive Income	$ 0	$ 4,876

4. Fair Value Measurements_ Sch

4. Fair Value Measurements: Schedule of Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details) - USD ($)	Dec. 31, 2015	Dec. 31, 2014
Assets:
Digital Currency	$ 5,203
Total assets measured at fair value	5,203	$ 4,876
Total liabilities measured at fair value	0	0
Available-for-sale securities	0	4,876
Fair Value, Inputs, Level 1
Assets:
Digital Currency	5,203
Total assets measured at fair value	5,203	4,876
Total liabilities measured at fair value	0	0
Available-for-sale securities		4,876
Fair Value, Inputs, Level 2
Assets:
Digital Currency	0
Total assets measured at fair value	0	0
Total liabilities measured at fair value	0	0
Available-for-sale securities		0
Fair Value, Inputs, Level 3
Assets:
Digital Currency	0
Total assets measured at fair value	0	0
Total liabilities measured at fair value	$ 0	0
Available-for-sale securities		$ 0

5. Hempcoins (Details)

5. Hempcoins (Details)	Dec. 31, 2015USD ($)	Dec. 31, 2014USD ($)
Details
Number of hempcoins held	110,000,000
Value of hempcoins held	$ 5,204	$ 0

6. Investment in Joint Venture

6. Investment in Joint Venture (Details)	12 Months Ended
	Dec. 31, 2015
IDEA | Hi-Brands International, Inc
Joint Venture Agreement	The Company and IDEA have agreed to share all revenues 50/50 and IDEA has agreed to pay the Company 50% of a $.50 shared fee per claim. The claim fee will increase based upon a set schedule as claims increase. The term of the agreement is for 3 years, but can be renewed for an additional three (3) year term periods. IDEA is charging the Company $35,000 as a set up fee and as part of the agreement IDEA is expected to generate 25,000 members/cardholders in the first year.

7. Fixed Assets and Intangibl41

7. Fixed Assets and Intangibles: Schedule of Property and Equipment (Details) - USD ($)	Dec. 31, 2015	Dec. 31, 2014
Less: accumulated depreciation	$ 6,104	$ 3,571
Property and Equipment, Net	4,504	7,037
Furniture and Fixtures
Property, Plant and Equipment, Gross	8,108	8,108
Leasehold Improvements
Property, Plant and Equipment, Gross	$ 2,500	$ 2,500

7. Fixed Assets and Intangibl42

7. Fixed Assets and Intangibles: Schedule of Intangible Assets (Details) - USD ($)	Dec. 31, 2015	Dec. 31, 2014
Intangible Assets, Net	$ 2,904,121	$ 2,999,292
Less: Accumulated Amortization	25,901	89,268
CBDS.com Website Cannabis Sativa
Intangible Assets, Net	13,999	13,999
Intellectual Property Rights Cannabis Sativa
Intangible Assets, Net	2,902,660	0
Intellectual Property Rights Kush
Intangible Assets, Net	0	3,060,000
Patents And Trademarks Cannabis Sativa
Intangible Assets, Net	8,938	0
Patents And Trademarks Kush
Intangible Assets, Net	0	10,136
Patents And Trademarks Wild Earth
Intangible Assets, Net	$ 4,425	$ 4,425

7. Fixed Assets and Intangibl43

7. Fixed Assets and Intangibles (Details)	12 Months Ended
	Dec. 31, 2015
K-Pal
Subsidiary or Equity Method Investee, Cumulative Percentage Ownership after All Transactions	90.00%

8. Due To Related Parties (Deta

8. Due To Related Parties (Details) - USD ($)	3 Months Ended		12 Months Ended
	Dec. 31, 2015	Sep. 30, 2015	Dec. 31, 2015	Dec. 31, 2014	Sep. 29, 2015
Short-term advances from related parties			$ 362,202
Net advances	$ 27,427		$ 27,427
Debt Instrument, Interest Rate, Stated Percentage	5.00%		5.00%
Interest Expense			$ 26,871	$ 26,497
Accrued Interest				5,667
Less: Accumulated Amortization	$ 25,901		25,901	89,268
Non-Controlling Interest	894		894	$ 894
Finite-Lived Intangible Assets, Gross	$ 3,060,000		$ 3,060,000
Preferred Stock, par or stated value	$ 0.001		$ 0.001	$ 0.001
Share Price	$ 1.1709769		$ 1.1709769		$ 2
Additional Paid-In Capital
Preferred Stock Issued due to Decrease in Market Value			$ (303)
K-Pal
Fair Value of Assets Acquired			8,938
Non-Controlling Interest	$ 894		894
Investor
Interest Expense			25,978
Officer 1
Accrued Interest	13,000		13,000
Steven Kubby
Due to Related Parties, Current and Long-term	3,060,000		3,060,000
Less: Accumulated Amortization	165,750		165,750
Intellectual property gross sales price	2,894,250		2,894,250
Liabilities Assumed			$ 2,890,499
Steven Kubby | Preferred Stock $ .001 Par
Stock Issued During Period, Purchase of Assets, Shares			1,500,000
Stock Issued During Period, Purchase of Assets, Value			$ 1,500
Stock Repurchased and Retired During Period, Shares			1,500,000
Stock Repurchased and Retired During Period, Value			$ 1,500
Steven Kubby | Additional Paid-In Capital
Stock Issued During Period, Purchase of Assets, Value			2,888,999
Three related parties
Debt Conversion, Original Debt, Amount			$ 857,170
Debt Conversion, Converted Instrument, Shares Issued		428,585
Preferred Stock Issued due to Decrease in Market Value	$ 303
Three related parties | Preferred Stock with No voting rights
Debt Conversion, Description			a contingency clause that should the common share price drop below $2 per share between October to December, 2015, then the average of the daily high and low price over those subsequent 90 days will be taken, and additional preferred shares will be issued to equal that average 90 day price.
Three related parties | Preferred Stock $ .001 Par
Debt Conversion, Converted Instrument, Shares Issued	303,433	428,585

9. Common Stock (Details)

9. Common Stock (Details) - USD ($)	3 Months Ended	6 Months Ended	12 Months Ended
	Dec. 31, 2015	Sep. 30, 2015	Dec. 31, 2015	Dec. 31, 2014
Shares Issued for Services, Value			$ 6,540,425	$ 1,000,000
Due to Related Parties - Short Term	$ 27,427		27,427	$ 2,472,086
Consultants
Shares Issued for Services, Value			3,500,000
Consulting expense			2,625,000
Consultants 2
Shares Issued for Services, Value			1,640,000
Consulting expense			1,640,000
Consultants 3
Shares Issued for Services, Value			84,800
Consulting expense			$ 84,800
Common Stock $ .001 Par
Shares Issued for Services, Shares			1,010,000	100,000
Shares Issued for Services, Value			$ 1,010	$ 100
Common Stock $ .001 Par | Consultants
Shares Issued for Services, Shares			500,000
Common Stock $ .001 Par | Consultants 2
Shares Issued for Services, Shares			200,000
Common Stock $ .001 Par | Consultants 3
Shares Issued for Services, Shares			80,000
Officer 1
Shares Issued for Services, Value			$ 690,000
Allocated Share-based Compensation Expense			$ 690,000
Officer 1 | Common Stock $ .001 Par
Shares Issued for Services, Shares			100,000
Director
Due to Related Parties - Short Term				$ 120,750
Professional Fees			$ 483,000
Director | Common Stock $ .001 Par
Shares Issued for Services, Shares			10,000	2,500
Officer 2
Shares Issued for Services, Value			$ 241,500
Officer 2 | Common Stock $ .001 Par
Shares Issued for Services, Shares			35,000
Eighth board member
Shares Issued for Services, Value	$ 5,125	$ 11,250
Eighth board member | Common Stock $ .001 Par
Shares Issued for Services, Shares	2,500	5,000

10. Preferred Stock (Details)

10. Preferred Stock (Details) - $ / shares	3 Months Ended		12 Months Ended
	Dec. 31, 2015	Sep. 30, 2015	Dec. 31, 2015	Dec. 31, 2014
Preferred Stock, shares authorized	5,000,000		5,000,000	5,000,000
Preferred Stock, par or stated value	$ 0.001		$ 0.001	$ 0.001
Steven Kubby | Preferred Stock $ .001 Par
Stock Issued During Period, Purchase of Assets, Shares			1,500,000
Spinoff, Common Stock Equivalent			1,500,000
Stock Repurchased and Retired During Period, Shares			1,500,000
Steven Kubby | Common Stock $ .001 Par
Stock Issued During Period, Purchase of Assets, Shares			17,289,304
Spinoff, Common Stock Equivalent			17,289,304
Kush | Common Stock $ .001 Par
Spinoff Exchange Ratio			4.3155
Kush spin-off date			Aug. 25, 2015
Additional ownership of Kush after spin-off	9.00%		9.00%
Shares issued in exchange for Kush shares			1,250,000
Three related parties
Debt Conversion, Converted Instrument, Shares Issued		428,585
Three related parties | Preferred Stock $ .001 Par
Debt Conversion, Converted Instrument, Shares Issued	303,433	428,585

11. Hi Brands International I47

11. Hi Brands International Inc. - Centuria Foods Agreement (Details) - Centuria Natural Foods, Inc.	12 Months Ended
	Dec. 31, 2015
Minimum Product Order Size, per month	5,000
Minimum Product Order Size	55,000

12. Going Concern Considerati48

12. Going Concern Considerations (Details) - USD ($)	Dec. 31, 2015	Dec. 31, 2014
Details
Accumulated Deficit	$ (54,093,099)	$ (46,915,104)

13. Commitments and Contingen49

13. Commitments and Contingencies (Details)	12 Months Ended
	Dec. 31, 2015USD ($)ft²	Dec. 31, 2014USD ($)
Details
Area of Real Estate Property | ft²	908
Monthly rent expense	$ (771.80)
Operating Leases, Rent Expense	$ (8,490)	$ (6,217)

15. Spin Off (Details)

15. Spin Off (Details) - Kush	12 Months Ended
	Dec. 31, 2015shares
Shares Issued by Spinoff Entity	14,260,436
Common Stock $ .001 Par
Spinoff Exchange Ratio	4.3155
Kush spin-off date	Aug. 25, 2015
Additional ownership of Kush after spin-off	9.00%

16. Subsequent Events (Details)

16. Subsequent Events (Details) - shares	1 Months Ended	12 Months Ended
	Mar. 31, 2016	Dec. 31, 2015	Dec. 31, 2014	Jan. 31, 2016
Common Stock $ .001 Par
Shares Issued for Services, Shares		1,010,000	100,000
Common Stock $ .001 Par | Consultants
Shares Issued for Services, Shares		500,000
Kush
Shares Issued by Spinoff Entity		14,260,436
Kush | Common Stock $ .001 Par
Spinoff Exchange Ratio		4.3155
Kush spin-off date		Aug. 25, 2015
Shares issued in exchange for Kush shares		1,250,000
Additional ownership of Kush after spin-off		9.00%
Subsequent Event | Common Stock $ .001 Par
Dividends Payable, Nature	the Company announced that it will pay a special stock dividend of 1.5 restricted common shares for each share held as of the record date of November 16, 2015. The holding period for these shares is 6 months from the issue date to shareholders of record.
Subsequent Event | Common Stock $ .001 Par | Consultants
Shares Issued for Services, Shares	30,000
Subsequent Event | Kush
Shares Issued by Spinoff Entity	14,260,436
Subsequent Event | Kush | Common Stock $ .001 Par
Spinoff Exchange Ratio	4.3155
Kush spin-off date	Aug. 25, 2015
Shares issued in exchange for Kush shares	1,250,000
Additional ownership of Kush after spin-off				9.00%